Northway Biotech is an end-to-end contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of protein-based biologics and gene therapies. With continuous expansion, 20+ years of technical expertise and a vertically integrated service model, we are uniquely positioned to rapidly execute multiple projects across development stages, from preclinical to commercial, while ensuring full regulatory compliance.
Our 3 state-of-the-art facilities in the EU (Vilnius, Lithuania) and US (Waltham, MA) include comprehensive capabilities for cell line development, process development, analytical development, as well as cGMP manufacturing of drug substances and drug products. Whether mammalian cell culture or microbial processing is optimal for your product's development, our cGMP facilities are equipped with multiple production units to support the development and manufacturing of your drug substance and aseptic drug product.
AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Diseases
Read MoreDiorasis Therapeutics and Northway Biotech Announce Partnership for the Development and Manufacturing of AAV Gene Therapy for Glaucoma
Read MoreOctober 28-30, 2025
Frankfurt, Germany
Booth 4.1G69 / Hall: H4.1
October 7-12, 2025
Sevilla, Spain
Booth C04
November 11-12, 2025
Vienna, Austria
Booth C#115
